1. Hagen PT, Scholz DG, Edwards WD: Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 59: 17-20, 1984.

2. Lynch L, Schuchard G, Gross C, Wann L: Prevalence of right-to-left atrial shunting in a healthy population: detection by Valsalva maneuver contrast echocardiography. Am J. Card 53: 1478-1480, 1984.

3. Chenzbraun A, Pinto FJ, Schnittger I: Biplane transesophageal echocardiography in the diagnosis of patent foramen ovale. J Am Soc Echocardiogr 6:417-421, 1993.

4. Harvey JR, Teague SM, Anderson JL, et al: Clinically Silent Atrial Septal Defects with Evidence for Cerebral Embolization. Annals of Internal Medicine 105:5:695-697, 1986.

5. Biller J, Johnson M, Adams H: Further observations on cerebral or retinal ischemia in patients with right-left intracardiac shunts. Arch Neurol 44: 740-743, 1987.

6. Hart R, Miller V: Cerebral infarction in young adults: a practical approach. Stroke 14: 100-114, 1983.

7. Jones H, Caplan L, Come P, Swinton N, Breslin D: Cerebral emboli of paradoxical origin. Ann Neurol 13: 314-319, 1983.

8. Connheim J: Thrombose und Embolie. Vorlesung uber Pathologie Bd 1, Berlin: Hirschwald: 175-177, 1877.

9. Job FP, Hanrath P: The diagnosis, clinical significance and therapy of patent foramen ovale. Dtsche Med Wochenschr 121:919-925, 1996.

10. Caes F, Van Belleghem YV, Missault LH, et al: Surgical treatment of impending paradoxical embolism through patent foramen ovale. Annals of Thoracic Surgery 1995; 59(6):1559-1561.

11. Begin R, Gervais A, Guerin L, et al: Patent foramen ovale and hypoxemia in chronic obstructive pulmonary disease. Eur J Respir Dis 62:373-375, 1981.

12. Knauth M, Ries S, Pohlmann S, et al: Cohort study of multiple brain lesions in sport divers: role of patent foramen ovale. BMJ 314:701-705, 1997.

13. Lechat Ph,Mas J L, Lascault G, et al:Prevalence of Patent Foramen ovale in Patients with Stroke. N Engl J Med 318: 1148-1152, 1988.

14. Mas JL: Patent foramen ovale, aneurysm of the interatrial septum and cerebral ischemic complication. Ann Cardiol Angeiol (Paris) 45:531-537, 1996.

15. Cabanes L, Mas JL, Cohen A, et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke 1993; 24:1865-1873.

16. Hausmann D, M¸gge A, Daniel WG. Identification of patent foramen ovale permitting paradoxical embolism. JACC 1995; 26:1030-1038.

17. Mas JL, Zuber M: Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. Am H J 1995; 130:1083-1088.

18. Bogousslavsky J, Garazi S, Jeanrenaud X, Aebischer, Van Melle G. Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Lausanne Stroke with Paradoxical embolism Study Group. Neurology 1996; 46:1301-1305.

19. Bogousslavsky J, Devuyst G, Nendaz M, Yamamoto H, Sarasin F. Prevention of stroke recurrence with presumed paradoxical embolism. J Neurol 1997; 244:71-5.

20. King T, Mills N: Nonoperative closure of atrial septal defects. Surgery 75:383-388, 1974.

21. King T, Thomson S, Steiner C, et al: Secundum atrial septal defect. Nonoperative closure during cardiac catheterization. JAMA 235:2506-2509, 1976.


Torna sù